Stay updated on Talazoparib in DNA Repair Defects Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new NIH website-transition notice appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:17:19.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:12:27.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This indicates an access restriction rather than an update to the study data.
    Difference
    18%
    Check dated 2026-09-22T20:50:24.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new page revision label, Revision: v3.7.0, was added, replacing the previous Revision: v3.6.6. This signals an update to the page version rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-15T20:39:00.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added the Revision: v3.6.6 tag. Removed Prostate cancer, related topics:, MedlinePlus Genetics, and Revision: v3.6.5 from the related topics area.
    Difference
    0.1%
    Check dated 2026-09-01T19:30:26.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Added related topic references and a grant/contract note to the study page, indicating indexing and topic associations rather than changes to trial design or eligibility. The additions include a 2016 NIH grant/contract line, and references to Prostate Cancer and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-08-25T20:43:43.000Z thumbnail image

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.